What is it about?
Genital infections are a frequent side effect of SGLT2 inhibitors, which are drugs used for type 2 diabetes. This study explores the characteristics of patients using SGLT2 inhibitors which are associated with a higher risk of genital infections. Smokers taking SGLT2 inhibitors have a considerably higher risk of genital infections than non-smokers.
Why is it important?
The identification of people at higher risk of side effects helps physicians in selecting the most appropriate drug for each patient.
Read the Original
This page is a summary of: Cigarette Smoking as a Predictor of Sodium–Glucose Cotransporter 2 Inhibitor–Associated Genital Infections: A Retrospective Cohort Study, Diabetes Care, April 2021, American Diabetes Association, DOI: 10.2337/dc21-0308.
You can read the full text:
The following have contributed to this page